Patricia M Kim, Reza Nejati, Pin Lu, Devang Thakkar, Nicholas Mackrides, Vanessa Dupoux, Shazia Nakhoda, Don A Baldwin, Jianming Pei, Sandeep S Dave, Y Lynn Wang, Mariusz Wasik
Diffuse large B-cell lymphoma (DLBCL) is a very heterogenous group, subdivided into germinal-center (GC)-derived and activated B-cell (ABC) types. Advances in molecular methodologies, including whole exome sequencing (WES) and chromosomal microarrays (CMA), have fostered molecular subclassification of DLBCL, while improving our understanding of their pathogenic mechanisms and resistance to therapy. Here we present distinct case of de novo DLBCL that presented in leukemic form. WES revealed point mutations of CD79B, MyD88, TP53, TBL1XR1 and PIM1 genes, indicating that this lymphoma with leukemic presentation fits the best the MCD/C5 molecular subtype of DLBCL, the prominent subcategory of the ABC DLBCL...
September 20, 2023: Cold Spring Harbor Molecular Case Studies